These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

222 related items for PubMed ID: 32301493

  • 1. Evidence for dimerization of ferroportin in a human hepatic cell line using proximity ligation assays.
    Rishi G, Secondes ES, Wallace DF, Subramaniam VN.
    Biosci Rep; 2020 May 29; 40(5):. PubMed ID: 32301493
    [Abstract] [Full Text] [Related]

  • 2. The molecular basis of ferroportin-linked hemochromatosis.
    De Domenico I, Ward DM, Nemeth E, Vaughn MB, Musci G, Ganz T, Kaplan J.
    Proc Natl Acad Sci U S A; 2005 Jun 21; 102(25):8955-60. PubMed ID: 15956209
    [Abstract] [Full Text] [Related]

  • 3. Structure-function analysis of ferroportin defines the binding site and an alternative mechanism of action of hepcidin.
    Aschemeyer S, Qiao B, Stefanova D, Valore EV, Sek AC, Ruwe TA, Vieth KR, Jung G, Casu C, Rivella S, Jormakka M, Mackenzie B, Ganz T, Nemeth E.
    Blood; 2018 Feb 22; 131(8):899-910. PubMed ID: 29237594
    [Abstract] [Full Text] [Related]

  • 4. The molecular basis of hepcidin-resistant hereditary hemochromatosis.
    Fernandes A, Preza GC, Phung Y, De Domenico I, Kaplan J, Ganz T, Nemeth E.
    Blood; 2009 Jul 09; 114(2):437-43. PubMed ID: 19383972
    [Abstract] [Full Text] [Related]

  • 5. Structural basis of ferroportin inhibition by minihepcidin PR73.
    Wilbon AS, Shen J, Ruchala P, Zhou M, Pan Y.
    PLoS Biol; 2023 Jan 09; 21(1):e3001936. PubMed ID: 36649314
    [Abstract] [Full Text] [Related]

  • 6. Resistance to hepcidin is conferred by hemochromatosis-associated mutations of ferroportin.
    Drakesmith H, Schimanski LM, Ormerod E, Merryweather-Clarke AT, Viprakasit V, Edwards JP, Sweetland E, Bastin JM, Cowley D, Chinthammitr Y, Robson KJ, Townsend AR.
    Blood; 2005 Aug 01; 106(3):1092-7. PubMed ID: 15831700
    [Abstract] [Full Text] [Related]

  • 7. Molecular pathogenesis of hereditary hemochromatosis.
    Liu J, Pu C, Lang L, Qiao L, Abdullahi MA, Jiang C.
    Histol Histopathol; 2016 Aug 01; 31(8):833-40. PubMed ID: 27031690
    [Abstract] [Full Text] [Related]

  • 8. Impact of D181V and A69T on the function of ferroportin as an iron export pump and hepcidin receptor.
    Praschberger R, Schranz M, Griffiths WJ, Baumgartner N, Hermann M, Lomas DJ, Pietrangelo A, Cox TM, Vogel W, Zoller H.
    Biochim Biophys Acta; 2014 Sep 01; 1842(9):1406-12. PubMed ID: 24859227
    [Abstract] [Full Text] [Related]

  • 9. Disruption of the hepcidin/ferroportin regulatory circuitry causes low axial bone mass in mice.
    Ledesma-Colunga MG, Baschant U, Fiedler IAK, Busse B, Hofbauer LC, Muckenthaler MU, Altamura S, Rauner M.
    Bone; 2020 Aug 01; 137():115400. PubMed ID: 32380257
    [Abstract] [Full Text] [Related]

  • 10. In vitro functional analysis of human ferroportin (FPN) and hemochromatosis-associated FPN mutations.
    Schimanski LM, Drakesmith H, Merryweather-Clarke AT, Viprakasit V, Edwards JP, Sweetland E, Bastin JM, Cowley D, Chinthammitr Y, Robson KJ, Townsend AR.
    Blood; 2005 May 15; 105(10):4096-102. PubMed ID: 15692071
    [Abstract] [Full Text] [Related]

  • 11. Calcium and IL-6 regulate the anterograde trafficking and plasma membrane residence of the iron exporter ferroportin to modulate iron efflux.
    Rosenblum SL, Bailey DK, Kosman DJ.
    J Biol Chem; 2024 Jun 15; 300(6):107348. PubMed ID: 38718866
    [Abstract] [Full Text] [Related]

  • 12. Expression of hepcidin and ferroportin in full term placenta of pregnant cows.
    Roperto S, Russo V, Urraro C, Cutarelli A, Perillo A, De Falco F, Roperto F.
    Theriogenology; 2017 Nov 15; 103():90-97. PubMed ID: 28780484
    [Abstract] [Full Text] [Related]

  • 13. Mice with hepcidin-resistant ferroportin accumulate iron in the retina.
    Theurl M, Song D, Clark E, Sterling J, Grieco S, Altamura S, Galy B, Hentze M, Muckenthaler MU, Dunaief JL.
    FASEB J; 2016 Feb 15; 30(2):813-23. PubMed ID: 26506980
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Effect of ferroportin polymorphism on iron homeostasis and infection.
    Kasvosve I.
    Clin Chim Acta; 2013 Feb 01; 416():20-5. PubMed ID: 23178444
    [Abstract] [Full Text] [Related]

  • 17. Human mutation D157G in ferroportin leads to hepcidin-independent binding of Jak2 and ferroportin down-regulation.
    De Domenico I, Lo E, Ward DM, Kaplan J.
    Blood; 2010 Apr 08; 115(14):2956-9. PubMed ID: 20124516
    [Abstract] [Full Text] [Related]

  • 18. Iron Availability in Tissue Microenvironment: The Key Role of Ferroportin.
    Gammella E, Correnti M, Cairo G, Recalcati S.
    Int J Mol Sci; 2021 Mar 15; 22(6):. PubMed ID: 33804198
    [Abstract] [Full Text] [Related]

  • 19. Non-mutagenic Suppression of Enterocyte Ferroportin 1 by Chemical Ribosomal Inactivation via p38 Mitogen-activated Protein Kinase (MAPK)-mediated Regulation: EVIDENCE FOR ENVIRONMENTAL HEMOCHROMATOSIS.
    Oh CK, Park SH, Kim J, Moon Y.
    J Biol Chem; 2016 Sep 16; 291(38):19858-72. PubMed ID: 27445333
    [Abstract] [Full Text] [Related]

  • 20. Alternative splicing generates a novel ferroportin isoform with a shorter C-terminal and an intact iron- and hepcidin-binding property.
    Juneja P, Rashid N, Abul Qais F, Tanwar S, Sultan I, Ahmad F, Rehman SU.
    IUBMB Life; 2024 Aug 16; 76(8):523-533. PubMed ID: 38348962
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.